“Decision to approve patent for embryo cell data could make IVF fertility treatments prohibitively expensive, says expert. A fresh international row has erupted over granting US patents to processes which many scientists believe are basic aspects of human physiology …” (more)
[Robin McKie, The Observer, 25 May]